US Patent Issued to Centre for Eye and Vision Research, The Hong Kong Polytechnic University on July 28 for "Treating refractive disorders by targeting peroxisome proliferator-activated receptor (PPAR) signaling pathway" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,106, issued on July 28, was assigned to Centre for Eye and Vision Research Ltd. (Hong Kong, Hong Kong) and The Hong Kong Polytechnic University (Hong Kong, Hong Kong).

"Treating refractive disorders by targeting peroxisome proliferator-activated receptor (PPAR) signaling pathway" was invented by Chuen Lam (Hong Kong, Hong Kong), Ying Hon Sze (Hong Kong, Hong Kong) and Yan Yin Tse (Hong Kong, Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmacologic treatment of refractive disorders, specifically myopia or hyperopia, by targeting the PPAR signaling pathway using a PPARGamma agonist without any binding to PPARAlpha. It is demonstrated t...